Abstract 4693: The selective ERK inhibitor BVD-523 is active in models of MAPK pathway-dependent cancers, including those with intrinsic and acquired drug resistance von Germann, Ursula, Furey, Brinley, Roix, Jeff, Markland, William, Hoover, Russell, Aronov, Alex, Hale, Michael, Chen, Guanjing, Martinez-Botella, Gabriel, Alargova, Rossitza, Fan, Bin, Sorrell, David, Meshaw, Kay, Shapiro, Paul, Wick, Michael J., Benes, Cyril, Garnett, Mathew, DeCrescenzo, Gary, Namchuk, Mark, Saha, Saurabh, Welsch, Dean J.

Volltext